sector medic suppli devic
 welcom start zimmer knee
messag six year ww recon share loss believ cusp
transform shift first inkl saw friday result recent
product launch knee busi posit net share taker start
view driven posit mix initi adopt rosa robot surgeri platform
analysi suggest top line growth acceler
back tailwind believ would result signific multipl expans
stock rais pt introduc
franchis potenti valu explain detail
year under-perform zimmer knee franchis cusp posit
inflect sinc estim compani lost ww recon market
share pro forma biomet deal under-perform pronounc
knee zimmer share period compar
hip disrupt biomet merger subsequ quality/suppli issu
repres real challeng compani believ zimmer revenu share loss
actual overst rel underli procedur volum specif rival
knee busi turbocharg posit mix launch
mako robot system shift cementless implant tailwind zimmer lack
chang follow recent launch zimmer rosa system
persona cementless implant persona zimmer popular knee model account
compani total implant behind triathlon term
 volum success recent year drive adopt cementless
version triathlon especi combin mako compani cementless mix
stand today meanwhil estim
knee procedur perform mako system two year
ago cementless implant carri price premium cement robot
procedur also ad dispos revenu per case mix shift
signific tailwind zimmer move full launch cementless version
persona end introduc rosa robot surgeri platform aao
march full roll-out schedul
introduc franchis potenti valu view launch
two product transform event zimmer knee busi one could drive
posit inflect compani overal growth rate lead multipl expans
stock importantli tailwind play minor role zimmer solid knee
growth cc bulk impact still come gaug potenti financi
impact associ sharehold valu creation shift analyz varieti
scenario three major variabl cementless implant mix rosa system placement
robot procedur mix base case assum zimmer cementless robot
mix rise respect compani place
mani robot system expect first three year follow mako tka
approv scenario reflect model estim zimmer
could earn per share appli multipl ep estim
deriv baselin franchis potenti valu
rais estim reiter buy rais estim take account
granular model zimmer potenti mix tailwind launch rosa
previous reflect forecast estim littl chang
expect financi impact factor rel limit year howev
believ zimmer knee busi could begin acceler soon
model diverg consensu time forecast street
top bottom line rais price target
take account revis estim reiter buy rate share
page analyst certif import disclosur
transform idea long-rang think structur chang
guggenheim transform idea seri seek identifi structur themat
technolog chang overlook investor due uncertain outcom
typic associ extend timelin requir execut transit
effort unearth long-term valu creation transform chang
identifi catalyst examin specif chang need occur lay
potenti timelin benchmark expect associ success
also attempt quantifi financi impact associ sharehold valu creation
success transform refer franchis potenti
franchis potenti valu repres price target franchis potenti
scenario analysi use illustr posit outcom long-term transform
zimmer knee busi cusp major inflect
transform idea report take in-depth look zimmer knee busi
zimmer persist laggard knee last year believ
recent product launch potenti drive meaning growth acceler
segment magnitud street current underestim importantli
posit inflect occur even zimmer procedur share remain flat current level
mix sale new rosa robot surgeri platform drive upsid
base case scenario reflect model yield top bottom line
growth zimmer estim consensu appli
multipl ep estim result franchis potenti valu
yearend meanwhil upsid case impli revenu
earn growth respect franchis potenti
valu ep
figur timelin valuat event benchmark catalyst
factset compani report guggenheim secur llc estim
page analyst certif import disclosur
year under-perform believ recent product launch zimmer
knee busi posit net share taker start knee account
zimmer biomet overal revenu make compani biggest product
categori leader world-wide knee market share
yet compani under-perform segment six year run pro forma
biomet global share fall period weak
attribut disrupt post biomet merger qualiti suppli
issu zimmer wrestl howev believ zimmer share loss
revenu basi also overst rel underli procedur volum
someth manag allud recent call specif compani
lack mix tailwind cementless implant robot procedur driven
sharp acceler stryker knee busi recent year hip impact
mix driver less pronounc zimmer share sinc
delta shed knee provid rough
approxim magnitud increment drag
mako receiv street attent success drive
cementless adopt arguabl big driver recent above-
market knee growth launch cementless version flagship triathlon knee
system littl five year ago fda approv use implant
combin mako octob kick shift high gear howev
stryker cementless knee mix benchmark player
market examin purchas data hospit figur
show cementless knee mix make signific outlier vs
competitor cementless mix low- mid-singl digit today
figur show price cement cementless femor compon trend
time averag premium cementless implant
zimmer limit presenc cementless knee segment
date trabecular metal porou biomateri track record
tantalum-bas construct featur structur function physiolog properti
similar bone encourag osteocyt ingrowth given histor issu loosen
cementless implant believ trabecular metal proven perform combin
high level surgeon experi cement persona system give
zimmer leg look drive cementless adopt
page analyst certif import disclosur
meanwhil weve encourag earli clinician feedback zimmer new
rosa robot surgeri platform rosa design fit seamlessli normal
workflow mako zimmer emphas potenti system
time-neutr limit surgeon experi case zimmer accomplish
streamlin calibr process increas arm stabil prevent system
need re-regist frequent rosa intuit interfac also allow
oper exist recon sale rep rather requir addit robot technician
room simplifi commun case initi convers
surgeon chanc use rosa suggest featur set signific
appeal less clear us point whether zimmer abl gener
improv clinic outcom rosa shown mako
highlight lack haptic bound cut plane rosa
disadvantag could potenti lead soft tissu injuri risk zimmer believ
overst
time long-term data compar clinic
perform two system success mako pave way
rosa launch idea robot role total knee arthroplasti much
wide accept today three year ago four major implant
manufactur push robot solut stryker mako instal base
system close domest estim system
equip perform tka procedur disclos roughli total
knee case done use robot past month math
impli compani tka volum perform robot today
penetr rate rise partial knee includ stryker
overal robot procedur volum mako tka caseload grew
respect compar
compani report guggenheim secur llc estim
compani report guggenheim secur llc estim
year miss robot revolut expect mani loyal zimmer
doc anxiou give rosa tri success help surgeon
use mako lure pull patient local advertis suspect
zimmer doc seen busi go across street recent year due
lack robot offer other may drawn simpli opportun combin
persona implant robot guidanc meanwhil sens rosa streamlin
workflow reson even surgeon regular mako user
page analyst certif import disclosur
estim potenti financi impact persona cementless rosa launch
could zimmer busi model rang scenario three main
variabl within compani knee busi cementless implant mix rosa system
placement robot procedur mix importantli three scenario
detail also includ sever baselin assumpt believ rel
conserv assum zimmer underli knee procedur share remain flat
knee market grow clip underli basi
implant price declin year consid impact mix
base case reflect model assum zimmer
total knee case cementless implant command
asp premium compani cement portfolio compar current
cementless mix meanwhil assum zimmer knee procedur
perform robot compar estim current
mako knee penetr zimmer wont benefit exist instal base
outset tka launch like believ assumpt reason
given increas surgeon comfort interest robot tka rel
first launch mako total knee applic combin assumpt
yield compound-annual-growth-rate zimmer knee busi layer
impact rosa system sale see figur compar neg
compound-annual-growth-rate compani post
compani report guggenheim secur llc estim
rosa placement base case scenario assum zimmer sell
system rise compar
mako system sold first two year total knee
launch mako placement model
page analyst certif import disclosur
note mako trajectori underst level interest tka applic
compani also upgrad system alreadi field partial
knee hip first two year tka avail result view rosa
assumpt conserv believ vast major mako system
sold outright make addit haircut zimmer estim base
assumpt rosa system place custom
altern financ agreement util contract could result compani
net result earn power model zimmer overal top line
growth rate acceler
weight averag market growth rate manag target long-rang
plan bottom line see ep growth ramp
outlook would put zimmer close large-cap med-tech
group averag growth rate top bottom line respect yet
broader group trade today appli multipl
ep estim deriv base case franchis valu yearend
figur timelin event benchmark catalyst
compani report guggenheim secur llc estim
long-term natur thesi like leav investor search metric
measur progress transform play asid quarterli knee
revenu sens zimmer unlik provid mani concret number around
rosa roll-out unlik report mako system sale within
ortho line zimmer lump rosa placement core knee busi
like make difficult ascertain mani system zimmer actual place
hope compani least give annual updat instal base aao
analyst meet also keep eye journal articl demonstr rosa
potenti improv clinic outcom initi public like come
meaning data avail late
progress cementless hospit purchas dataset allow us track
near real time resourc make use new med-tech
data insight public draw sku-level medic devic purchas inform
 hospit overal countri fairli accur
represent broader domest hip knee market time
page analyst certif import disclosur
bull case scenario depict green box/bar figur figur assum
zimmer mix robot cementless knee procedur rise essenti
line mix today also assum compani rosa placement match
stryker mako trajectori first three year mako tka launch note
believ latter assumpt rel conserv given fact stryker
also upgrad close mako system exist instal base first two
year launch process manag said distract sale forc
pursu new placement case base case scenario bull case
continu assum zimmer underli knee procedur share remain flat
knee market grow clip underli basi implant
price declin year consid impact mix
combin assumpt yield compound-annual-growth-rate zimmer knee busi
base case scenario also boost compani
overal project top line growth meanwhil yield
ep estim deriv upsid case franchis potenti valu
appli multipl forecast line current large-cap med-tech averag
multipl
bear case scenario depict red box/bar figur figur assum
zimmer fail gain much traction either rosa persona cementless robot
cementless penetr respect
assum compani pace rosa placement run
stryker mako sale meanwhil maintain conserv
assumpt zimmer underli knee procedur share broader knee market
growth price
combin assumpt yield compound-annual-growth-rate zimmer knee busi
base case scenario bull case
also lower compani overal project top line growth
meanwhil yield ep estim deriv downsid case
franchis potenti valu appli multipl forecast modest
premium zimmer current ntm multipl
page analyst certif import disclosur
zimmer merger biomet made player hip knee wide
margin share global recon sale deal provid compani
ep accret scale also left zimmer sale come slow growth
market underperform late under-perform
exacerb past two year chronic manufactur issu suppli
constraint leav zimmer unabl servic client base effect recent remedi
effort address issu howev combin sever new key product
launch posit compani drive improv top line growth profit
move see zimmer knee busi particular
cusp meaning growth acceler driven compani rosa
robot surgeri system persona cementless implant believ improv knee
growth help boost overal compani top line gain lead
signific multipl expans process
zimmer share current trade ntm ep estim ntm
ebitda well large-cap med-tech averag view
discount broader group justifi given zimmer inferior top line growth trajectori
vs see current valuat gap excess expect share
re-rat upward compani begin show sign growth acceler
rais price target base previous
multipl revis forward ntm ep estim signific upsid potenti
target current level assign zimmer share buy rate
downsid risk rate includ disappoint traction key new product
launch particular rosa robot surgeri system persona cementless knee
implant increas price and/or volum pressur ortho implant manufactur
failur complet resolv quality/suppli issu weigh zimmer result
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
